Membranous Nephropathy: Pilot Study of a Novel Regimen Combining Cyclosporine and Rituximab

INTRODUCTION: There is broad consensus that high-grade basal proteinuria and failure to achieve remission of proteinuria are key determinants of adverse renal prognosis in patients with primary membranous nephropathy. Since current regimens are not ideal due to short- and long-term toxicity and prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Waldman, Meryl, Beck, Laurence H., Braun, Michelle, Wilkins, Kenneth, Balow, James E., Austin, Howard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138549/
https://www.ncbi.nlm.nih.gov/pubmed/27942609
http://dx.doi.org/10.1016/j.ekir.2016.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138549/
https://www.ncbi.nlm.nih.gov/pubmed/27942609
http://dx.doi.org/10.1016/j.ekir.2016.05.002

Ejemplares similares